HAVCR2 and neoplasm: However, the tumor-infiltrated Tregs include heterogeneous subsets of cells expressing different immunosuppressive molecules favoring tumor progression, such as CTLA-4, PD-1, LAG-3, TIM-3, and TIGIT.